NLRP3 inflammasome has also been shown to be regulated by PI3K/Akt signaling in atherosclerosis and inhibitors of PI3K (GDC0941) and Akt (MK2206) significantly reduced the activation of NLRP3 and expression levels of p-p65/p65. Here, NLRP3 is linked to atherosclerosis.